UX strategy and experience design for regulated healthcare and pharma brands.
↓ 20% drop-off · Abbott FreeStyle Libre · 15+ yrs healthcare & pharma
Each engagement started with a diagnostic question, not a design assumption.
From upstream diagnosis through execution — the full arc of UX strategy in regulated environments.
Every decision has a defensible rationale — built into the brief before anyone opens a design tool. When teams understand the structural reasoning behind an architecture decision, they can defend it in stakeholder review without me in the room.
Regulated engagements rarely arrive with clean briefs. Strong framing at the start — the right diagnostic question, the right structural model — is what keeps cross-market and multi-stakeholder work from fracturing mid-execution.
In regulated environments, UX decisions that can't survive medical, regulatory, and legal review simultaneously don't ship. I build teams that understand this isn't a compliance problem — it's a design problem. The rationale gets baked in from the start.
"Competitive audits used to run once a quarter. Now they run continuously — and that changes what they're for."
AI has made competitive intelligence a live strategic layer — running continuously, surfacing patterns at scale, and changing when in the process key decisions get made.
"The interface is usually the last place the problem lives."
When a healthcare experience fails, the instinct is to redesign the interface. A case for upstream diagnosis — and what changes when you treat the interface as a symptom, not the cause.